Moderna's Cancer-Vaccine Breakthrough Drives Broad Biopharma Stock Rally

3-line summary

• Moderna's cancer-vaccine breakthrough drove a broad rally across biopharma stocks, according to MarketWatch.
• The biopharmaceutical sector had struggled with a prolonged downturn in recent years but has been on an upswing of late.

This summary is our own processing of the source article; see the source link below for full context.